Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE: 603456)
Health Care · Pharmaceuticals · CN
CN¥16.75
+3.14% today · -18.7% 1Y
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE: 603456) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.15B and employs 4,791 people.
Over the last twelve months the share price has lost 18.7%, trading between 12.05 and 22.25.
Tweenvest scores Zhejiang Jiuzhou Pharmaceutical Co., Ltd across four factors: quality 73/100, value 61/100, growth 75/100, dividend 64/100. Its strongest factor is growth.
603456 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.15B
- Revenue (TTM)
- $767.41M
- P/E
- 25.05
- EPS
- 0.67
- Dividend yield
- 1.19%
- Beta (5Y)
- 0.13
- 52-week high
- CN¥22.25
- 52-week low
- CN¥12.05
- Avg volume (3M)
- —
- Shares outstanding
- 859.19M
- Employees
- 4,791
- Next earnings
- —
About Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Zhejiang Jiuzhou Pharmaceutical Co., Ltd, a company established in 1973 and operating from its headquarters in Taizhou, China, specializes in the production and global supply of active pharmaceutical ingredients (APIs) and their chemical precursors. Its extensive product catalog includes APIs designed for a wide range of therapeutic applications, encompassing treatments for central nervous system disorders (such as anti-depressants and Parkinson's disease), various infectious ailments (including antiviral, general anti-infection, and specific respiratory anti-infection agents), diabetes management, non-steroidal drugs, oncological therapies, Hepatitis C, and cardiovascular conditions. Furthermore, beyond its pharmaceutical focus, the company also furnishes specialized asymmetric catalysts and crucial materials utilized in lithium-ion batteries.
- ISIN
- CNE100001W36
- Founded
- 1973
- Listed since
- Oct 10, 2014
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Haw Par Corporation LimitedSGX: H02 | $2.19B | S$12.70 | -2.31% |
| Pharvaris N.V.NasdaqGS: PHVS | $2.19B | $31.12 | -0.22% |
| Tonghua Golden-Horse Pharmaceutical Industry Co,LtdSZSE: 000766 | $2.18B | CN¥15.16 | -0.20% |
| Shilpa Medicare LimitedBSE: 530549 | $2.16B | Rs1,063.65 | +5.06% |
| China Resources Jiangzhong Pharmaceutical Co.,LtdSHSE: 600750 | $2.12B | CN¥22.60 | +0.31% |
| Dermapharm Holding SEXTRA: DMP | $2.12B | €38.15 | -1.93% |
| Grand Pharmaceutical Group LimitedSEHK: 512 | $2.11B | HK$4.74 | -1.76% |
| Granules India LimitedBSE: 532482 | $2.11B | Rs820.80 | -5.80% |
Figures last refreshed Oct 4, 2026.